Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile
General Stock Board Listed Company Profile
Code:
Industry:
Local/Foreign Company:
6497 ASLAN-KY
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Andrew James Howden Carl Firth Carl Firth +65 6222 4235 37F, 100 Songren Rd , XinYi Dist, Taipei City 110, TaiwanTaipei 11073, Taiwan 2017/06/01
Agent for litigious
and non-litigious matters
Tel of
Agent for litigious
and non-litigious matters
Address of
Agent for litigious
and non-litigious matters
Brandon Wei 0237257770 37F, 100 Songren Rd , XinYi Dist, Taipei City 110, Taiwan
Industry Main Business
Biotechnology and Medical Care
亞獅康私人有限公司(ASLAN Pharmaceutical Pte. Ltd.)係依專注於腫瘤、開發免疫療法與標靶抗癌藥物之生物科技公司。
 
Market Information ( 2019/11/19 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
26.731 5.27  5.27  5.27  -0.58  26 0.01 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2019/11/20)
TPEx measures
adopted
(2019/11/20)
With warrants Can be shorted or margined? Detail
變更交易(分盤) Y N N N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.